NCT02557074 TREg Activation in the Treatment of the PELADE (Alopecia Areata) Status COMPLETED Phase PHASE3
NCT02553330 A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA) Status TERMINATED Phase PHASE2
NCT02350023 Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata Status COMPLETED Phase PHASE4
NCT02312882 Tofacitinib for the Treatment of Alopecia Areata and Its Variants Status COMPLETED Phase NA
NCT02299297 Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis Status COMPLETED Phase PHASE2
NCT02037191 The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade Status COMPLETED Phase PHASE3
NCT02018042 An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata Status COMPLETED Phase PHASE2
NCT01950780 Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata Status COMPLETED Phase PHASE2
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01917058 A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata Status WITHDRAWN Phase PHASE2
NCT01898806 Intralesional Steroids in the Treatment of Alopecia Areata Status TERMINATED Phase PHASE4
NCT01840046 Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata Status TERMINATED Phase PHASE1/PHASE2
NCT01797432 Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata Status COMPLETED Phase PHASE2
NCT01559584 Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata Status COMPLETED Phase NA
NCT01453686 A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata Status COMPLETED Phase PHASE3